Cargando…
The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.
BACKGROUND: The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has presented itself as one of the most important health concerns of the 2020’s, and hit the geriatric population the hardest. The presence of co-morbidities and immune ageing in the elderl...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581120/ https://www.ncbi.nlm.nih.gov/pubmed/34763723 http://dx.doi.org/10.1186/s13690-021-00715-z |
_version_ | 1784596735616614400 |
---|---|
author | Goossens, Maria E. Neven, Kristof Y. Pannus, Pieter Barbezange, Cyril Thomas, Isabelle Gucht, Steven Van Dierick, Katelijne Schmickler, Marie-Noëlle Verbrugghe, Mathieu Loon, Nele Van Ariën, Kevin K Marchant, Arnaud Goriely, Stanislas Desombere, Isabelle |
author_facet | Goossens, Maria E. Neven, Kristof Y. Pannus, Pieter Barbezange, Cyril Thomas, Isabelle Gucht, Steven Van Dierick, Katelijne Schmickler, Marie-Noëlle Verbrugghe, Mathieu Loon, Nele Van Ariën, Kevin K Marchant, Arnaud Goriely, Stanislas Desombere, Isabelle |
author_sort | Goossens, Maria E. |
collection | PubMed |
description | BACKGROUND: The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has presented itself as one of the most important health concerns of the 2020’s, and hit the geriatric population the hardest. The presence of co-morbidities and immune ageing in the elderly lead to an increased susceptibility to COVID-19, as is the case for other influenza-like illnesses (ILI) or acute respiratory tract infections (ARI). However, little is known, about the impact of a previous or current infection on the other in terms of susceptibility, immune response, and clinical course. The aim of the “Prior Infection with SARS-COV-2” (PICOV) study is to compare the time to occurrence of an ILI or ARI between participants with a confirmed past SARS-CoV-2 infection (previously infected) and those without a confirmed past infection (naïve) in residents and staff members of nursing homes. This paper describes the study design and population characteristics at baseline. METHODS: In 26 Belgian nursing homes, all eligible residents and staff members were invited to participate, resulting in 1,226 participants. They were classified as naïve or previously infected based on the presence of detectable SARS-CoV-2 antibodies and/or a positive RT-qPCR result before participation in the study. Symptoms from a prior SARS-CoV-2 infection between March and August 2020 were compared between previously infected residents and staff members. RESULTS: Infection naïve nursing home residents reported fewer symptoms than previously infected residents: on average 1.9 and 3.1 symptoms, respectively (p = 0.016). The same effect was observed for infection naïve staff members and previously infected staff members (3.1 and 6.1 symptoms, respectively; p <0.0001). Moreover, the antibody development after a SARS-CoV-2 infection differs between residents and staff members, as previously infected residents tend to have a higher rate of asymptomatic cases compared to previously infected staff members (20.5% compared to 12.4%; p <0.0001). CONCLUSIONS: We can postulate that COVID-19 disease development and symptomatology are different between a geriatric and younger population. Therefore, the occurrence and severity of a future ILI and/or ARI might vary from resident to staff. |
format | Online Article Text |
id | pubmed-8581120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85811202021-11-12 The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms. Goossens, Maria E. Neven, Kristof Y. Pannus, Pieter Barbezange, Cyril Thomas, Isabelle Gucht, Steven Van Dierick, Katelijne Schmickler, Marie-Noëlle Verbrugghe, Mathieu Loon, Nele Van Ariën, Kevin K Marchant, Arnaud Goriely, Stanislas Desombere, Isabelle Arch Public Health Research BACKGROUND: The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has presented itself as one of the most important health concerns of the 2020’s, and hit the geriatric population the hardest. The presence of co-morbidities and immune ageing in the elderly lead to an increased susceptibility to COVID-19, as is the case for other influenza-like illnesses (ILI) or acute respiratory tract infections (ARI). However, little is known, about the impact of a previous or current infection on the other in terms of susceptibility, immune response, and clinical course. The aim of the “Prior Infection with SARS-COV-2” (PICOV) study is to compare the time to occurrence of an ILI or ARI between participants with a confirmed past SARS-CoV-2 infection (previously infected) and those without a confirmed past infection (naïve) in residents and staff members of nursing homes. This paper describes the study design and population characteristics at baseline. METHODS: In 26 Belgian nursing homes, all eligible residents and staff members were invited to participate, resulting in 1,226 participants. They were classified as naïve or previously infected based on the presence of detectable SARS-CoV-2 antibodies and/or a positive RT-qPCR result before participation in the study. Symptoms from a prior SARS-CoV-2 infection between March and August 2020 were compared between previously infected residents and staff members. RESULTS: Infection naïve nursing home residents reported fewer symptoms than previously infected residents: on average 1.9 and 3.1 symptoms, respectively (p = 0.016). The same effect was observed for infection naïve staff members and previously infected staff members (3.1 and 6.1 symptoms, respectively; p <0.0001). Moreover, the antibody development after a SARS-CoV-2 infection differs between residents and staff members, as previously infected residents tend to have a higher rate of asymptomatic cases compared to previously infected staff members (20.5% compared to 12.4%; p <0.0001). CONCLUSIONS: We can postulate that COVID-19 disease development and symptomatology are different between a geriatric and younger population. Therefore, the occurrence and severity of a future ILI and/or ARI might vary from resident to staff. BioMed Central 2021-11-11 /pmc/articles/PMC8581120/ /pubmed/34763723 http://dx.doi.org/10.1186/s13690-021-00715-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Goossens, Maria E. Neven, Kristof Y. Pannus, Pieter Barbezange, Cyril Thomas, Isabelle Gucht, Steven Van Dierick, Katelijne Schmickler, Marie-Noëlle Verbrugghe, Mathieu Loon, Nele Van Ariën, Kevin K Marchant, Arnaud Goriely, Stanislas Desombere, Isabelle The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms. |
title | The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms. |
title_full | The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms. |
title_fullStr | The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms. |
title_full_unstemmed | The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms. |
title_short | The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms. |
title_sort | prior infection with sars-cov-2 study (picov) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms. |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581120/ https://www.ncbi.nlm.nih.gov/pubmed/34763723 http://dx.doi.org/10.1186/s13690-021-00715-z |
work_keys_str_mv | AT goossensmariae thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT nevenkristofy thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT pannuspieter thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT barbezangecyril thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT thomasisabelle thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT guchtstevenvan thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT dierickkatelijne thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT schmicklermarienoelle thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT verbrugghemathieu thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT loonnelevan thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT arienkevink thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT marchantarnaud thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT gorielystanislas thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT desombereisabelle thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT goossensmariae priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT nevenkristofy priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT pannuspieter priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT barbezangecyril priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT thomasisabelle priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT guchtstevenvan priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT dierickkatelijne priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT schmicklermarienoelle priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT verbrugghemathieu priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT loonnelevan priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT arienkevink priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT marchantarnaud priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT gorielystanislas priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms AT desombereisabelle priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms |